Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice
Ha-Na Lee, Mohanraj Manangeeswaran, Aaron P. Lewkowicz, Kaliroi Engel, Monica Chowdhury, Mamatha Garige, Michael A. Eckhaus, Carole Sourbier, Derek D.C. Ireland, Daniela Verthelyi
Ha-Na Lee, Mohanraj Manangeeswaran, Aaron P. Lewkowicz, Kaliroi Engel, Monica Chowdhury, Mamatha Garige, Michael A. Eckhaus, Carole Sourbier, Derek D.C. Ireland, Daniela Verthelyi
View: Text | PDF
Research Article Immunology Infectious disease

NK cells require immune checkpoint receptor LILRB4/gp49B to control neurotropic Zika virus infections in mice

  • Text
  • PDF
Abstract

Immune cells express an array of inhibitory checkpoint receptors that are upregulated upon activation and limit tissue damage associated with excessive response to pathogens or allergens. Mouse leukocyte immunoglobulin like receptor B4 (LILRB4), also known as glycoprotein 49B (gp49B), is an inhibitory checkpoint receptor constitutively expressed in myeloid cells and upregulated in B cells, T cells, and NK cells upon activation. Here, we report that expression of LILRB4, which binds Zika virus (ZIKV), was increased in microglia and myeloid cells infiltrating the brains of neonatal mice with ZIKV-associated meningoencephalitis. Importantly, while C57BL/6 mice developed transient neurological symptoms but survived infection, mice lacking LILRB4/gp49B (LILRB4 KO) exhibited more severe signs of neurological disease and succumbed to disease. Their brains showed increased cellular infiltration but reduced control of viral burden. The reduced viral clearance was associated with altered NK cell function in the absence of LILRB4/gp49B. In naive animals, this manifested as reduced granzyme B responses to stimulation, but in ZIKV-infected animals, NK cells showed phenotypic changes that suggested altered maturation, diminished glucose consumption, reduced IFN-γ and granzyme B production, and impaired cytotoxicity. Together, our data reveal LILRB4/gp49B as an important regulator of NK cell function during viral infections.

Authors

Ha-Na Lee, Mohanraj Manangeeswaran, Aaron P. Lewkowicz, Kaliroi Engel, Monica Chowdhury, Mamatha Garige, Michael A. Eckhaus, Carole Sourbier, Derek D.C. Ireland, Daniela Verthelyi

×

Figure 3

LILRB4 deficiency drives hyperactivation of macrophages and microglia induced by IFN-γ.

Options: View larger image (or click on image) Download as PowerPoint
LILRB4 deficiency drives hyperactivation of macrophages and microglia in...
(A) Binding of ZIKV to recombinant mouse LILRB4 (mLILRB4) and human LILRB4 (hLILRB4) proteins. Data are representative of 3 independent experiments (triplicates, each). (B) Bone marrow–derived macrophages (BMDMs) from WT and LILRB4-KO mice were infected with pHrodo-stained ZIKV for 0 or 60 minutes in vitro, and cells having internalized ZIKV (pHrodo+) were determined by flow cytometry analysis. The plots show the percentage of pHrodo+ BMDMs. Data shown as means ± SD of 3 independent experiments. (C and D) Flow cytometry analysis of MHC class II–positive (MHCII-positive) microglia (C) and macrophages (D) in the brains of ZIKV-infected WT and LILRB4-KO mice at 15 dpi (n = 3, each group). The graphs show the percentage of MHCII+ cells in microglia (CD45intCD11b+) (C) and macrophages (CD45hiCD11b+F4/80+) (D), respectively. (E and F) mRNA expression of I-Ab on BMDM from WT and LILRB4-KO mice after stimulation with ZIKV (MOI 1), IFN-β (10 ng/mL), or IFN-γ (10 ng/mL) (E) or IFN-γ at different doses (F) for 24 hours. Data shown as means ± SD of 3 independent experiments. (G) mRNA expression of Ifngr on BMDMs from WT and LILRB4-KO mice. Data shown as means ± SD (n = 3). Data were analyzed using 2-tailed unpaired Student’s t test. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts